⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for fractionated first dose rituximab

Every month we try and update this database with for fractionated first dose rituximab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study on Fractionated Rituximab to Avoid Lysis Syndrome in Aggressive B-LymphomaNCT05840289
Aggressive B-Ce...
fractionated fi...
- University Hospital, Geneva
A Study on Fractionated Rituximab to Avoid Lysis Syndrome in Aggressive B-LymphomaNCT05840289
Aggressive B-Ce...
fractionated fi...
- University Hospital, Geneva
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: